GENEVA, Oct. 26 -- CANSINO BIOLOGICS INC. (401-420, 4th Floor, West District Biomedical Park, No.185 South Street, Economic And Technological Development Zone West DistrictBinhai New Area, Tianjin 300457), 康希诺生物股份公司 (中国天津市滨海新区经济技术开发区西区南大街185号西区生物医药园四层401-420) filed a patent application (PCT/CN2025/088983) for "RECOMBINANT ADENOVIRUS VECTOR VACCINE FORMULATION AND PREPARATION METHOD THEREFOR" on Apr 15, 2025. With publication no. WO/2025/218651, the details related t...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.